
Page#1
Item 8. Financial statements and supplementary data
WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
At August 31, 2017 and 2016
(in millions, except shares and per share amounts)
2017 2016
Assets
Current assets:
Cash and cash equivalents $ 3,301 $ 9,807
Accounts receivable, net 6,528 6,260
Inventories 8,899 8,956
Other current assets 1,025 860
Total current assets 19,753 25,883
Non-current assets:
Property, plant and equipment, net 13,642 14,335
Goodwill 15,632 15,527
Intangible assets, net 10,156 10,302
Equity method investments (see note 5) 6,320 6,174
Other non-current assets 506 467
Total non-current assets 46,256 46,805
Total assets $66,009 $72,688
Liabilities and equity
Current liabilities:
Short-term borrowings $ 251 $ 323
Trade accounts payable (see note 18) 12,494 11,000
Accrued expenses and other liabilities 5,473 5,484
Income taxes 329 206
Total current liabilities 18,547 17,013
Non-current liabilities:
Long-term debt 12,684 18,705
Deferred income taxes 2,281 2,644
Other non-current liabilities 4,223 4,045
Total non-current liabilities 19,188 25,394
Commitments and contingencies (see note 11)
Equity:
Preferred stock $.01 par value; authorized 32 million shares, none issued — —
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at August 31,
2017 and 2016 12 12
Paid-in capital 10,339 10,111
Employee stock loan receivable — (1)
Retained earnings 30,137 27,684
Accumulated other comprehensive loss (3,051) (2,992)
Treasury stock, at cost; 148,664,548 shares at August 31, 2017 and 89,527,027 at August 31, 2016 (9,971) (4,934)
Total Walgreens Boots Alliance, Inc. shareholders’ equity 27,466 29,880
Noncontrolling interests 808 401
Total equity 28,274 30,281
Total liabilities and equity $66,009 $72,688
The accompanying notes to Consolidated Financial Statements are an integral part of these Statements.
- 67 -
Page#2
WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
For the years ended August 31, 2017, 2016 and 2015
(in millions, except per share amounts)
2017 2016 2015
Sales $118,214 $117,351 $103,444
Cost of sales 89,052 87,477 76,691
Gross profit 29,162 29,874 26,753
Selling, general and administrative expenses 23,740 23,910 22,400
Equity earnings in AmerisourceBergen 135 37 —
Equity earnings in Alliance Boots — — 315
Operating income 5,557 6,001 4,668
Gain on previously held equity interest — — 563
Other income (expense) (11) (261) 685
Earnings before interest and income tax provision 5,546 5,740 5,916
Interest expense, net 693 596 605
Earnings before income tax provision 4,853 5,144 5,311
Income tax provision 760 997 1,056
Post tax earnings from other equity method investments 8 44 24
Net earnings 4,101 4,191 4,279
Net earnings attributable to noncontrolling interests 23 18 59
Net earnings attributable to Walgreens Boots Alliance, Inc. $ 4,078 $ 4,173 $ 4,220
Net earnings per common share:
Basic $ 3.80 $ 3.85 $ 4.05
Diluted $ 3.78 $ 3.82 $ 4.00
Dividends declared per share $ 1.525 $ 1.455 $ 1.373
Weighted average common shares outstanding:
Basic 1,073.5 1,083.1 1,043.2
Diluted 1,078.5 1,091.1 1,053.9
The accompanying notes to Consolidated Financial Statements are an integral part of these Statements.
- 69 -
Page#3
WALGREENS BOOTS ALLIANCE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the years ended August 31, 2017, 2016 and 2015
(in millions)
2017 2016 2015
Cash flows from operating activities:
Net earnings $ 4,101 $ 4,191 $ 4,279
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization 1,654 1,718 1,742
Change in fair value of warrants and related amortization — 516 (779)
Gain on previously held equity interest — — (563)
Deferred income taxes (434) (442) (32)
Stock compensation expense 91 115 109
Equity earnings from equity method investments (143) (81) (339)
Other 364 148 752
Changes in operating assets and liabilities:
Accounts receivable, net (153) 115 (338)
Inventories 98 (644) 719
Other current assets — 66 22
Trade accounts payable 1,690 1,572 268
Accrued expenses and other liabilities (128) 313 170
Income taxes 44 202 (335)
Other non-current assets and liabilities 67 58 (11)
Net cash provided by operating activities 7,251 7,847 5,664
Cash flows from investing activities:
Additions to property, plant and equipment (1,351) (1,325) (1,251)
Proceeds from sale leaseback transactions 444 60 867
Proceeds from sale of businesses — 74 814
Proceeds from sale of other assets 59 155 184
Alliance Boots acquisition, net of cash acquired — — (4,461)
Business and intangible asset acquisitions, net of cash acquired (88) (126) (371)
Investment in AmerisourceBergen — (2,360) —
Other 93 5 (58)
Net cash used for investing activities (843) (3,517) (4,276)
Cash flows from financing activities:
Proceeds and payments of short-term borrowings, net 33 29 (226)
Proceeds from issuance of long-term debt — 5,991 12,285
Payments of long-term debt (6,196) (791) (10,472)
Stock purchases (5,220) (1,152) (1,226)
Proceeds related to employee stock plans 217 235 503
Cash dividends paid (1,723) (1,563) (1,384)
Other (45) (143) (395)
Net cash (used for) provided by financing activities (12,934) 2,606 (915)
Effect of exchange rate changes on cash and cash equivalents 20 (129) (119)
Changes in cash and cash equivalents:
Net (decrease) increase in cash and cash equivalents (6,506) 6,807 354
Cash and cash equivalents at beginning of period 9,807 3,000 2,646
Cash and cash equivalents at end of period $ 3,301 $ 9,807 $ 3,000
The accompanying notes to Consolidated Financial Statements are an integral part of these Statements.
- 71 -